128 related articles for article (PubMed ID: 34531148)
1. Inducible CRISPRa screen identifies putative enhancers.
Dai Z; Li R; Hou Y; Li Q; Zhao K; Li T; Li MJ; Wu X
J Genet Genomics; 2021 Oct; 48(10):917-927. PubMed ID: 34531148
[TBL] [Abstract][Full Text] [Related]
2. Discovery of stimulation-responsive immune enhancers with CRISPR activation.
Simeonov DR; Gowen BG; Boontanrart M; Roth TL; Gagnon JD; Mumbach MR; Satpathy AT; Lee Y; Bray NL; Chan AY; Lituiev DS; Nguyen ML; Gate RE; Subramaniam M; Li Z; Woo JM; Mitros T; Ray GJ; Curie GL; Naddaf N; Chu JS; Ma H; Boyer E; Van Gool F; Huang H; Liu R; Tobin VR; Schumann K; Daly MJ; Farh KK; Ansel KM; Ye CJ; Greenleaf WJ; Anderson MS; Bluestone JA; Chang HY; Corn JE; Marson A
Nature; 2017 Sep; 549(7670):111-115. PubMed ID: 28854172
[TBL] [Abstract][Full Text] [Related]
3. Generation and validation of versatile inducible CRISPRi embryonic stem cell and mouse model.
Li R; Xia X; Wang X; Sun X; Dai Z; Huo D; Zheng H; Xiong H; He A; Wu X
PLoS Biol; 2020 Nov; 18(11):e3000749. PubMed ID: 33253175
[TBL] [Abstract][Full Text] [Related]
4. Combinatorial genetics in liver repopulation and carcinogenesis with a in vivo CRISPR activation platform.
Wangensteen KJ; Wang YJ; Dou Z; Wang AW; Mosleh-Shirazi E; Horlbeck MA; Gilbert LA; Weissman JS; Berger SL; Kaestner KH
Hepatology; 2018 Aug; 68(2):663-676. PubMed ID: 29091290
[TBL] [Abstract][Full Text] [Related]
5. An inducible CRISPR-ON system for controllable gene activation in human pluripotent stem cells.
Guo J; Ma D; Huang R; Ming J; Ye M; Kee K; Xie Z; Na J
Protein Cell; 2017 May; 8(5):379-393. PubMed ID: 28116670
[TBL] [Abstract][Full Text] [Related]
6. CRISPR-Mediated Activation of Transposable Elements in Embryonic Stem Cells.
Sakashita A; Ariura M; Namekawa SH
Methods Mol Biol; 2022; 2509():171-194. PubMed ID: 35796964
[TBL] [Abstract][Full Text] [Related]
7. Massively parallel characterization of CRISPR activator efficacy in human induced pluripotent stem cells and neurons.
Wu Q; Wu J; Karim K; Chen X; Wang T; Iwama S; Carobbio S; Keen P; Vidal-Puig A; Kotter MR; Bassett A
Mol Cell; 2023 Apr; 83(7):1125-1139.e8. PubMed ID: 36917981
[TBL] [Abstract][Full Text] [Related]
8. Activation of Young LINE-1 Elements by CRISPRa.
Tong B; Sun Y
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203595
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Mammalian In Vivo Enhancers Using Mouse Transgenesis and CRISPR Genome Editing.
Osterwalder M; Tran S; Hunter RD; Meky EM; von Maydell K; Harrington AN; Godoy J; Novak CS; Plajzer-Frick I; Zhu Y; Akiyama JA; Afzal V; Kvon EZ; Pennacchio LA; Dickel DE; Visel A
Methods Mol Biol; 2022; 2403():147-186. PubMed ID: 34913122
[TBL] [Abstract][Full Text] [Related]
10. Generating CRISPR/Cas9 Mediated Monoallelic Deletions to Study Enhancer Function in Mouse Embryonic Stem Cells.
Moorthy SD; Mitchell JA
J Vis Exp; 2016 Apr; (110):e53552. PubMed ID: 27078492
[TBL] [Abstract][Full Text] [Related]
11. Characterization of transcriptional enhancers in the chicken genome using CRISPR-mediated activation.
Han JH; Lee HJ; Kim TH
Front Genome Ed; 2023; 5():1269115. PubMed ID: 37953873
[TBL] [Abstract][Full Text] [Related]
12. Bidirectional manipulation of gene expression in adipocytes using CRISPRa and siRNA.
Lundh M; Pluciñska K; Isidor MS; Petersen PSS; Emanuelli B
Mol Metab; 2017 Oct; 6(10):1313-1320. PubMed ID: 29031730
[TBL] [Abstract][Full Text] [Related]
13. CAPTURE: In Situ Analysis of Chromatin Composition of Endogenous Genomic Loci by Biotinylated dCas9.
Liu X; Zhang Y; Chen Y; Li M; Shao Z; Zhang MQ; Xu J
Curr Protoc Mol Biol; 2018 Jul; 123(1):e64. PubMed ID: 29927077
[TBL] [Abstract][Full Text] [Related]
14. Targeted CRISPR activation is functional in engineered human pluripotent stem cells but undergoes silencing after differentiation into cardiomyocytes and endothelium.
Karbassi E; Padgett R; Bertero A; Reinecke H; Klaiman JM; Yang X; Hauschka SD; Murry CE
Cell Mol Life Sci; 2024 Feb; 81(1):95. PubMed ID: 38372898
[TBL] [Abstract][Full Text] [Related]
15. Multiplex, single-cell CRISPRa screening for cell type specific regulatory elements.
Chardon FM; McDiarmid TA; Page NF; Daza RM; Martin B; Domcke S; Regalado SG; Lalanne JB; Calderon D; Li X; Starita LM; Sanders SJ; Ahituv N; Shendure J
bioRxiv; 2024 Apr; ():. PubMed ID: 37034704
[TBL] [Abstract][Full Text] [Related]
16. A Novel Eukaryote-Like CRISPR Activation Tool in Bacteria: Features and Capabilities.
Liu Y; Wang B
Bioessays; 2020 Jun; 42(6):e1900252. PubMed ID: 32310310
[TBL] [Abstract][Full Text] [Related]
17. Multiplex gene editing to promote cell survival using low-pH clustered regularly interspaced short palindromic repeats activation (CRISPRa) gene perturbation.
Levis H; Weston J; Austin B; Larsen B; Ginley-Hidinger M; Gullbrand SE; Lawrence B; Bowles RD
Cytotherapy; 2023 Oct; 25(10):1069-1079. PubMed ID: 37245150
[TBL] [Abstract][Full Text] [Related]
18. In vivo CRISPRa decreases seizures and rescues cognitive deficits in a rodent model of epilepsy.
Colasante G; Qiu Y; Massimino L; Di Berardino C; Cornford JH; Snowball A; Weston M; Jones SP; Giannelli S; Lieb A; Schorge S; Kullmann DM; Broccoli V; Lignani G
Brain; 2020 Mar; 143(3):891-905. PubMed ID: 32129831
[TBL] [Abstract][Full Text] [Related]
19. CRISPR activation screens: navigating technologies and applications.
Clark T; Waller MA; Loo L; Moreno CL; Denes CE; Neely GG
Trends Biotechnol; 2024 Mar; ():. PubMed ID: 38493051
[TBL] [Abstract][Full Text] [Related]
20. Scaffold-based non-viral CRISPR delivery platform for efficient and prolonged gene activation to accelerate tissue regeneration.
Zhong C; He S; Huang Y; Yan J; Wang J; Liu W; Fang J; Ren F
Acta Biomater; 2024 Jan; 173():283-297. PubMed ID: 37913843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
